(Adnkronos) - La musica classica come metafora della ricerca scientifica. Su queste note Lilly lancia la campagna “#SavingTime. Più tempo grazie alla ricerca sui tumori del sangue” che, nel mese dedicato alla sensibilizzazione su queste neoplasie, porterà la musica classica in luoghi all’aperto alle prime luci dell’alba. Tre i concerti aperti al pubblico: uno a Roma, in collaborazione con il Conservatorio S. Cecilia, il 14 settembre. Uno a Napoli, con la partecipazione del Conservatorio di Musica di San Pietro a Majella, il 21 e uno a Milano, con i musicisti dell’Orchestra Sinfonica del Conservatorio di Musica “Giuseppe Verdi” del capoluogo meneghino, il 28.
Category
🗞
NewsTranscript
00:00Classical music as a metaphor for scientific research.
00:08On these notes, Lilly launches the campaign Saving Time,
00:11more time thanks to the research on blood tumors,
00:14which in the month dedicated to the awareness of these neoplasies
00:18will bring classical music to the open, at the first lights of dawn.
00:23A symbol of change in the fight against hematological neoplasies.
00:27Three concerts open to the public, one in Rome on September 14,
00:31one in Naples on the 21st and one in Milan on the 28th.
00:35Blood tumors represent 10% of all tumors.
00:39Only in Italy, more than half a million people live there.
00:43These are neoplasies that can also be very aggressive.
00:4770% of patients affected by oncological and hematological diseases are alive at 10 years old.
00:52A good part of them are cured.
00:55Unfortunately, there are no prevention or diagnosis factors for hematological and hematological diseases,
01:01so diagnosis in many cases can not be an early diagnosis,
01:05but it is a rather late diagnosis.
01:08However, we have certainly interesting results,
01:11especially in recent years they are evolving,
01:14they are better evolving the approach of patients,
01:18keeping the prospects of healing and long-term survival always better.
01:23Thanks to scientific research, medicine has made significant steps forward
01:27in the treatment of hematological neoplasies.
01:30We have gradually moved from chemotherapy to biological therapies.
01:34Very often therapies that can be taken by mouth
01:38and therefore do not even need an infusion or a needle in the vein.
01:43So they are drugs that are much better tolerated
01:46because they are more specific on certain specific mechanisms of the disease,
01:51so they give less of those systemic effects,
01:54generalized effects of the side effects that we knew in chemotherapy.
01:59The Save in Time campaign marks the entry of Lilly in hematology,
02:03a strong signal that represents the commitment of the pharmaceutical company
02:08so that more therapies are available for patients.
02:11In the last ten years we have seen that research has given new possibilities for patients.
02:18We have seen a rate of survival that is higher and also of care,
02:25but at the level of awareness and knowledge from the public,
02:29we have work to do.
02:32For this reason, we are trying to launch this campaign
02:37and to take classical music, which is always hidden in theaters and concerts,
02:45to take it out of these venues, to the public,
02:49just as the research that we do is always hidden in our laboratories.
02:56We also want to take it and give the public an idea of the challenges
03:04that patients with blood tumors face every day.